Dr Sue Pavord:’It was scary. I was a mother of three kids in their 20s, and these were the people we were seeing dying’ - Christopher Pledger When Oxford University developed the AstraZeneca vaccine, ...
ZURICH (Reuters) - U.S. regulators have recommended pausing the use of Johnson & Johnson's COVID-19 vaccine as they investigate rare blood clotting in six women, including one who died. J&J also said ...
An investigation published by The BMJ today raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval for the anti-platelet drug ticagrelor (Brilinta in the ...
LONDON — Europe's medicines regulator found a possible link between the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood clotting issues — though it said the ...
Researchers from the University of Liverpool’s Centre for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Adults under 30 years of age will be offered an alternative vaccine to the AstraZeneca/Oxford ...
Norway halted the rollout of the AstraZeneca vaccine on Thursday, following a similar move by Denmark. Iceland later followed suit. “We do not know if the cases are linked to the vaccine,” Sigurd ...
The announcement comes months after AstraZeneca admitted in court documents that it can cause a rare and dangerous side effect, Reuters is reporting. “As multiple, variant COVID-19 vaccines have since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback